Reduced monocyte HLA-DR and CD86 suggest that the monocyte phenotype in sepsis may be driving an anti-inflammatory phenotype in T-lymphocytes; supporting the utility of monocyte HLA-DR as a biomarker to identify patients with sepsis immunoparalysis. The gene discussed is CD86; the disease is Sepsis.